Literature DB >> 15271721

Aspirin withdrawal and acute lower limb ischemia.

Pierre Albaladejo1, Thomas Geeraerts, Fady Francis, Yves Castier, Guy Lesèche, Jean Marty.   

Abstract

Aspirin is used mainly to prevent arterial events in patients with arteriopathy. Myocardial infarction and cerebrovascular events have been described after recent aspirin withdrawal. Experimental data suggest rebound platelet activity after aspirin discontinuation. Among a retrospective cohort of 181 patients admitted for acute lower limb ischemia for 4 yr, we studied 11 patients who had recently stopped taking aspirin. Aspirin was administered for vascular event prevention. The median duration of aspirin treatment without vascular events was 12 mo (range, 6-60 mo). The median time between aspirin withdrawal and lower limb ischemia was 23 days (range, 7-60 days). Four of the 11 patients stopped aspirin before a surgical procedure, without any substitution. In five patients, a recent diagnosis of neoplasia was observed. This study should alert clinicians to the risk of discontinuing chronic aspirin therapy in patients with severe peripheral vascular disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15271721     DOI: 10.1213/01.ANE.0000131965.61686.BD

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  2 in total

1.  Thrombotic events associated to aspirin therapy.

Authors:  Christian Doutremepuich; Omar Aguejouf; Vanessa Desplat; Dominique Duprat; Francisco X Eizayaga
Journal:  Thrombosis       Date:  2011-11-24

2.  The role of point-of-care assessment of platelet function in predicting postoperative bleeding and transfusion requirements after coronary artery bypass grafting.

Authors:  Pankaj Kumar Mishra; Joyce Thekkudan; Raj Sahajanandan; Mike Gravenor; Suresh Lakshmanan; Khazi Mohammed Fayaz; Heyman Luckraz
Journal:  Ann Card Anaesth       Date:  2015 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.